CLINICAL_TRIALS
trial_result
· 2022-11-30
Clinical Trial Update: Platelet Inhibition in Patients With Systolic Heart Failure [Phase 4]
Summary
Phase 4 trial update on platelet inhibition in patients with systolic heart failure; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Nebraska | Conditions: Systolic Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2022-11-30